iShares MSCI Intl Momentum Factor ETF (ARCA: IMTM)

Latest news for iShares MSCI Intl Momentum Factor ETF (ARCA:IMTM)

iShares Edge MSCI Intl Momentum Factor ETF

iShares MSCI International Momentum Factor ETF

Financial Services

Industrials

Consumer Cyclical

Technology

Healthcare

Basic Materials

Energy

Consumer Defensive

Communication Services

Utilities

Other

Real Estate

The Fund seeks to track the investment results of the MSCI World ex USA Momentum Index (the Underlying Index), which consists of stocks exhibiting relatively higher momentum characteristics than the traditional market capitalization-weighted parent index, the MSCI World ex USA Index (the Parent Index), as determined by MSCI Inc. (the Index Provider or MSCI). The Parent Index includes equity securities in approximately the top 85% of equity market capitalization in developed market countries, as defined by the Index Provider, excluding the U.S. The Underlying Index is designed to reflect the performance of an equity momentum strategy that emphasizes stocks with high price momentum, while maintaining reasonably high trading liquidity, investment capacity and moderate index turnover.

Novo Nordisk As

Asml Holding N.V.

Toyota Motor Corp

Sap Ag Ord Npv

Hitachi Ltd. [6501]

Schneider Electric Se

iShares MSCI Intl Momentum Factor ETF

WIIM

iPower shares are trading lower after the company reported worse-than-expected Q4 revenue results.

Susquehanna analyst James Friedman maintains Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>) with a Positive and lowers the price target from $66 to $55.

News

Price Target

Analyst Ratings

DAVA

Susquehanna Maintains Positive on Endava, Lowers Price Target to $55

Susquehanna analyst James Friedman initiates coverage on Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) with a Positive rating and announces Price Target of $52.

Initiation

AFRM

Susquehanna Initiates Coverage On Affirm Holdings with Positive Rating, Announces Price Target of $52

JMP Securities analyst Silvan Tuerkcan reiterates Exelixis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXEL#NASDAQ">EXEL</a>) with a Market Outperform and maintains $29 price target.

Reiteration

EXEL

JMP Securities Reiterates Market Outperform on Exelixis, Maintains $29 Price Target

PBF Energy shares are trading lower after Piper Sandler downgraded the stock from Neutral to Underweight and lowered its price target from $47 to $25.

Macro Economic Events

Market Summary

Economics

General

MSFT

Benzinga Market Summary: FedEx Falls After Q1 Earnings, Constellation Energy Rises With Microsoft Deal, Trump Media & Technology Group Lockup Period Expires

Stifel analyst Daniel Arias maintains Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Buy and raises the price target from $615 to $680.

Stifel Maintains Buy on Thermo Fisher Scientific, Raises Price Target to $680

Stifel analyst J. Bruce Chan maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Buy and lowers the price target from $327 to $321.

Stifel Maintains Buy on FedEx, Lowers Price Target to $321

Barclays analyst Eddie Kim maintains Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) with a Overweight and lowers the price target from $55 to $54.

Barclays Maintains Overweight on Noble Corp, Lowers Price Target to $54

Stifel analyst Shlomo Rosenbaum maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Hold and raises the price target from $451 to $469.

Stifel Maintains Hold on FactSet Research Systems, Raises Price Target to $469

Stephens &amp; Co. analyst Daniel Imbro reiterates FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Overweight and maintains $350 price target.

Stephens & Co. Reiterates Overweight on FedEx, Maintains $350 Price Target

Barclays analyst Andrew Lazar maintains General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) with a Equal-Weight and raises the price target from $67 to $74.

Barclays Maintains Equal-Weight on General Mills, Raises Price Target to $74

Barclays analyst Raimo Lenschow maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Equal-Weight and lowers the price target from $106 to $90.

ESTC

Barclays Maintains Equal-Weight on Elastic, Lowers Price Target to $90

Stifel analyst Steven Wieczynski maintains Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) with a Buy and raises the price target from $25 to $27.

Stifel Maintains Buy on Carnival, Raises Price Target to $27

A generational divide is emerging in the investment strategies of America&#8217;s wealthy, with younger millionaires increasingly shunning traditional stock market investments in favor of <a href="https://www.benzinga.com/alternative-investments">riskier, alternative assets</a>. The shift, experts caution, may reflect a short-term mindset that could potentially hinder long-term wealth accumulation.
Don't Miss:
<ul>
<li>One trailblazing female with an expertise in renewable energy built a company that's bringing the EV revolution to disadvantaged communities —<a href="https://www.benzinga.com/money/dunamis-1"> here&#8217;s how you can invest at just $500</a></li>
<li>General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a></li>
</ul>
According to the 2024 Bank of America Private Bank Study of Wealthy Americans, only 28% of wealthy individuals aged 21 to 43 believe achieving above-average returns with stocks and bonds is possible. That stands in contrast to their older counterparts, with 72% of those 44 and older expressing confidence in classic investing practices.
The study surveyed individuals with at least $3 million in investable assets and found that younger wealthy investors rank stocks behind seven other investment types, including real estate, cryptocurrency and private equity. The preference for alternative investments comes despite the historical performance of the broad U.S. stock market, which has returned an average of 10% annually over the past century when accounting for reinvested dividends.
Trending: Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.
Brad Klontz, a certified financial planner and professor of financial psychology at Creighton University, suggests that the divide in investment strategies may be rooted in cognitive biases common among younger investors, regardless of wealth level.
&#8220;The desire to push against conventional wisdom is a really important developmental stage,&#8221; Klontz explained to CNBC. &#8220;Young people on social media tell me that [traditional investing advice] isn&#8217;t how it&#8217;s done anymore. Everything&#8217;s changed. This is something that people have been saying for thousands of years.&#8221;
Trending: The startup behind White Castle's favorite Robot Fry Cook announces a next-generation fast food robot –<a href="https://www.benzinga.com/money/miso-robotics-flippy"> Here's how to get a share for under $5 today.</a>
Klontz said that the allure of cryptocurrencies and other alternative assets often stems from a <a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40580243/crypto-trader-turns-5-000-into-millions-shares-key-insights-from-his-journey-looking-in-hi">desire for rapid wealth accumulation</a>. &#8220;When it comes to some of the tried-and-true approaches to investing, it really is a long game. And when I hear people talk about crypto and alternative assets, that&#8217;s much more of a short-game mindset. They&#8217;re probably interested in making money faster.&#8221;
Another factor driving young millionaires&#8217; investment choices is the perceived exclusivity of certain assets. Real estate, private equity deals and direct investments into companies all require substantial capital, often beyond the reach of average investors. That barrier to entry can create a false sense of superiority in those investments.
Trending: Teens may never need wisdom teeth removed thanks to this MedTech Company –<a href="https://www.benzinga.com/money/triagenics"> Be an early investor for just $300 for 100 shares!</a>
However, Klontz warns against conflating exclusivity with superior returns. He told CNBC that investors can gain exposure to the S&amp;P 500 for a minimal fee through its exchange-traded fund (ETF), SPDR S&amp;P 500 ETF Trust. Over the past 30 years, the market index has outperformed the U.S. residential real estate market and it carries less risk.
Trending: A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a>
The preference for exclusive investments may also come at a cost. According to the report, private equity funds, for instance, often charge fees of 1.5% to 2% of invested assets annually, plus 20% of annual profits above a certain threshold. &#8220;We&#8217;re all inherently obsessed with our status. Denying it just tells me that you&#8217;re psychologically immature,&#8221; Klontz said.
While alternative investments may offer the potential for high returns, they also come with increased risks. Young millionaires will have to balance their desire for novel investment opportunities with the proven track record of traditional market investments.
Read Next:
<ul>
<li>Groundbreaking trading app with a ‘Buy-Now-Pay-Later' feature for stocks tackles the $644 billion margin lending market –<a href="https://www.benzinga.com/money/wolfpack"> here&#8217;s how to get equity in it with just $500</a></li>
<li>This billion-dollar fund has invested in the next big real estate boom,<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> here's how you can join for $10.</a></li>
</ul>

Startups

Young Millionaires Favor Risky Bets Over Stocks – And Experts Warn Crypto And Alt Assets Are 'Much More Of A Short-Game Mindset'

Barclays analyst Adrienne Yih maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Overweight, adjusts target to $180 from $1090 (Forward Stock Split 6:1).

DECK

Barclays Maintains Overweight on Deckers Outdoor, Adjusts Price Target To $180 (Forward Stock Split 6:1)

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGIO#NASDAQ">AGIO</a>) with a Overweight.

AGIO

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticals

VinFast Auto Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) shares are <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">trading lower in the morning session on Friday.</a>
The company reported a second-quarter <a target="_blank" href="https://www.sec.gov/Archives/edgar/data/1913510/000110465924101517/tm2424378d1_ex99-1.htm" rel="noreferrer noopener">loss per share </a>of 33 cents, missing the street view of a 21-cent loss. Quarterly sales of $357.4 million missed the <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">analyst consensus of $460.09 million.</a>
&#8220;We have acknowledged some headwinds and uncertainties adversely challenging EV outlook at this point of time in some markets..,&#8221; said Thuy Le, Chairwoman of VinFast.&nbsp;
EV deliveries&nbsp;were 13,172 in the second quarter, representing an increase of 43% year over year.
E-scooter deliveries were 13,076 in the second quarter, representing an increase of 28% year over year.
As of August&nbsp;31, the company had 155 showrooms globally for EVs and 180 showrooms and service workshops for e-scooters, including VinFast showrooms and dealer showrooms.
The company made a strategic decision to adjust the operational timeline for the North Carolina plant to 2028 to allow VinFast to optimize resources to focus on achieving near-term growth targets.
&#8220;With the delivery of VF 3 starting in Q3, we have completed the development of all 7 e-SUV models, besides a comprehensive portfolio of 9 e-scooters, e-bus and e-bike,&#8221; Le added.
The company held cash and equivalents&nbsp;of $98.2 million as of June.
Outlook: The company reaffirmed its FY2024 target to<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> deliver 80,000 electric vehicles (EVs).</a>
Lan Anh Nguyen, Chief Financial Officer of VinFast, said, &#8220;One key driver for us in Q2 growth was the increased reception of customers for VinFast's EVs in Vietnam. This growth in our home market has been crucial in advancing our mission to promote EV adoption and green mobility&#8230;At the same time, we continue to focus on cost optimization and stringent capital allocation while maintaining a level of flexibility in our capex plans and continuing to grow our top line.&#8221;
Price Action: VFS shares are trading lower by 3.79% to $3.81 at last check Friday.
Image via Shutterstock
Don&#8217;t miss the opportunity to dominate in a volatile market at the <a href="https://www.benzinga.com/events/small-cap/global-small-cap-conference-2024/" target="_blank" rel="noreferrer noopener">Benzinga SmallCAP Conference</a> on Oct. 9-10 at the Chicago Marriott Downtown Magnificent Mile. Get exclusive access to CEO presentations, 1:1 meetings with investors, and valuable insights from top financial experts. Whether you&#8217;re a trader, entrepreneur, or investor, this event offers unparalleled opportunities to grow your portfolio and network with industry leaders. Secure your spot and get your tickets today!

Earnings

Equities

Guidance

Markets

Movers

VinFast Hits Roadblock: Fails To Meet Q2 Earnings And Sales Expectations, Cautions On Challenging Macro EV Outlook

New clinical efficacy and safety data for arimoclomol as a possible treatment for Niemann-Pick disease type C, including from long-term and real-world settings, demonstrate clinically meaningful reduction in disease progression &nbsp;
Arimoclomol was well tolerated during the Open Label Extension trial and Early Access Program with no safety signals identified
PK modeling studies showed that administration of OLPRUVA while fasting vs fed results in higher drug exposure which may allow for lower effective dosages when taken without food

ZVRA

Zevra Therapeutics Presents New Data For Arimoclomol, OLPRUVA At SSIEM 2024 Symposium

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are trading lower following recent strength. Worse-than-expected Q1 financial results and weak guidance from FedEx may have also weighed on stocks.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

iShares MSCI Intl Momentum Factor ETF

News

Latest news for iShares MSCI Intl Momentum Factor ETF (ARCA:IMTM)